Article

Tightening Schlemm's canal reduces IOP

Tensioning of Schlemm's canal may reduce intraocular pressure (IOP) in non-penetrating surgical treatment of open angle glaucoma (OAG), according to the results of a study conducted by Manfred Tetz and colleagues from Germany.

Tensioning of Schlemm's canal may reduce intraocular pressure (IOP) in non-penetrating surgical treatment of open angle glaucoma (OAG), according to the results of a study conducted by Manfred Tetz and colleagues from Germany.

During a multicentre clinical study at four European and six US outpatient surgical centres, Schlemm's canal was exposed by surgical dissection during viscocanalostomy of 92 eyes. A flexible microcannula was inserted and advanced along the circumference to viscodilate the canal. Then a 10-0 prolene suture was tied to the tip of the microcannula and retracted into the canal and the suture ends were tied to apply tension to the inner wall and the trabecular meshwork. In 33 patients, the trabecular meshwork distension was measured using high resolution ultrasound imaging and correlated to IOP at one, three and six months postoperatively.

Average preoperative IOP was recorded at 27.8 mmHg on 2.0 medications. Six months postoperatively, 19 eyes with low suture tension had an average IOP of 15.0 mmHg on 0.13 medications as compared with 14 eyes with high suture tension whose average IOP was 13.6 mmHg on 0.10 medications.

The authors concluded that there is a correlation between reduced postoperative IOP and increased tension and that by tensioning Schlemm's canal it may be possible to reduce IOP in non-penetrating surgical treatment of OAG.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.